Emvose Trio 2mg/500mg/0.2mg Tablet
Marketer
Medopharm
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Emvose Trio 2mg/500mg/0.2mg Tablet
Triveo 2 mg/500 mg/0.2 mg tablets are classified as antidiabetic medications, specifically a combination therapy for adult-onset type 2 diabetes. This medication helps manage blood glucose levels. Triveo should be taken with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Emvose Trio 2mg/500mg/0.2mg Tablet
There is no text provided to rephrase.
Uses of Emvose Trio 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Emvose Trio 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Emvose Trio 2 mg/500 mg/0.2 mg Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer on an empty stomach.
Common Side effects of Emvose Trio 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Emvose Trio 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Emvose Trio 2 mg/500 mg/0.2 mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Emvose Trio 2mg/500mg/0.2mg Tablet works:
Emvose Trio tablets (2 mg/500 mg/0.2 mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Emvose Trio 2 mg/500 mg/0.2 mg tablets with alcohol is not advised due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Emvose Trio 2 mg/500 mg/0.2 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against any possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Emvose Trio 2 mg/500 mg/0.2 mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Emvose Trio 2 mg/500 mg/0.2 mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, the use of Emvose Trio 2 mg/500 mg/0.2 mg Tablets is discouraged for individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Emvose Trio 2 mg/500 mg/0.2 mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a reduced dosage; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Emvose Trio 2mg/500mg/0.2mg Tablet :
Should you forget a dose of Emvose Trio 2 mg/500 mg/0.2 mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Emvose Trio 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently